Panacea Life Sciences Holdings annual return on equity
2016
2019
2020
2021
2022
Panacea Life Sciences Holdings Return on Equity (ROE) Growth & History (PLSH)
Panacea Life Sciences Holdings's return on equity was −368.81% for fiscal 2022.
View full Panacea Life Sciences Holdings company overviewPanacea Life Sciences Holdings annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −368.81% | −299.56 pp |
| 2021 | 2021-12-31 | −69.26% | −13.15 pp |
| 2020 | 2020-12-31 | −56.11% | +179.19 pp |
| 2019 | 2019-12-31 | −235.30% | — |
| 2016 | 2016-12-31 | −227.89% | — |
Panacea Life Sciences Holdings quarterly return on equity
Q2.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q3 2022 | 2022-09-30 | −297.00% | −265.91 pp |
| Q2 2022 | 2022-06-30 | −60.97% | −61.27 pp |
| Q1 2022 | 2022-03-31 | −49.32% | −54.69 pp |
| Q4 2021 | 2021-12-31 | −26.98% | −37.56 pp |
| Q3 2021 | 2021-09-30 | −31.08% | +12.43 pp |
| Q2 2021 | 2021-06-30 | 0.29% | −5.99 pp |
| Q1 2021 | 2021-03-31 | 5.38% | +30.80 pp |
| Q4 2020 | 2020-12-31 | 10.59% | +56.86 pp |
| Q3 2020 | 2020-09-30 | −43.52% | −10.16 pp |
| Q2 2020 | 2020-06-30 | 6.29% | +63.86 pp |
| Q1 2020 | 2020-03-31 | −25.42% | — |
| Q4 2019 | 2019-12-31 | −46.28% | — |
| Q3 2019 | 2019-09-30 | −33.36% | — |
| Q2 2019 | 2019-06-30 | −57.57% | — |
| Q3 2017 | 2017-09-30 | −1,220.48% | −1173.44 pp |
| Q2 2017 | 2017-06-30 | −75.47% | −24.59 pp |
| Q1 2017 | 2017-03-31 | −49.59% | +892.86 pp |
| Q4 2016 | 2016-12-31 | −69.61% | — |
| Q3 2016 | 2016-09-30 | −47.04% | — |
| Q2 2016 | 2016-06-30 | −50.88% | +463.27 pp |
| Q1 2016 | 2016-03-31 | −942.45% | — |
| Q2 2015 | 2015-06-30 | −514.15% | — |
Panacea Life Sciences Holdings return on equity trends
Between the periods ended 2016-12-31 and 2022-12-31, Panacea Life Sciences Holdings's return on equity decreased from −227.89% to −368.81%, a change of −140.92 percentage points. The latest reported quarter, Q3 2022, shows −297.00%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Panacea Life Sciences Holdings source filings ↗